| The synthetic diazonamide DZ-2384 has distinct effects on microtubule curvature and dynamics without neurotoxicity M Wieczorek, J Tcherkezian, C Bernier, AE Prota, S Chaaban, Y Rolland, ... Science translational medicine 8 (365), 365ra159-365ra159, 2016 | 47 | 2016 |
| Rgs16 and Rgs8 in embryonic endocrine pancreas and mouse models of diabetes A Villasenor, ZV Wang, LB Rivera, O Ocal, IW Asterholm, PE Scherer, ... Disease Models & Mechanisms 3 (9-10), 567-580, 2010 | 46 | 2010 |
| A rapid in vivo screen for pancreatic ductal adenocarcinoma therapeutics O Ocal, V Pashkov, RK Kollipara, Y Zolghadri, VH Cruz, MA Hale, ... Disease models & mechanisms 8 (10), 1201-1211, 2015 | 18 | 2015 |
| Malnutrition in pancreatic ductal adenocarcinoma (PDA): Dietary pancreatic enzymes improve short-term health but stimulate tumor growth Y Zolghadri, SP Choudhuri, O Ocal, S Layeghi-Ghalehsoukhteh, F Berhe, ... The American Journal of Pathology 188 (3), 616-626, 2018 | 8 | 2018 |
| Concerted cell and in vivo screen for pancreatic ductal adenocarcinoma (PDA) chemotherapeutics S Layeghi-Ghalehsoukhteh, S Pal Choudhuri, O Ocal, Y Zolghadri, ... Scientific Reports 10 (1), 20662, 2020 | 3 | 2020 |
| Rgs16 is an early marker of pancreatic ductal adenocarcinoma (842.7) O Ocal, B Heath, L Rivera, V Pashkov, G Swift, R Brekken, T Wilkie The FASEB Journal 28, 842.7, 2014 | 2 | 2014 |
| A rapid in vivo screen for pancreatic ductal adenocarcinoma therapeutics using the tumor marker Rgs16::GFP O Ocal, V Pashkov, RK Kollipara, JB Lorens, GH Swift, RA Brekken, ... Cancer Research 76 (14_Supplement), 5182-5182, 2016 | 1 | 2016 |
| Investigation of oncogenic G‐protein coupled receptor signaling pathways in Kras dependent pancreatic cancer cell lines O Ocal, R MacDonald, RA Brekken, T Wilkie The FASEB Journal 33 (S1), 647.29-647.29, 2019 | | 2019 |
| Rgs8 and Rgs16 are tumor suppressor genes in mouse pancreatic ductal adenocarcinoma SP Choudhuri, Y Zolghadri, L Mascarenhas, O Ocal, T Wilkie Cancer Research 77 (13_Supplement), 5518-5518, 2017 | | 2017 |
| Publications List of the Pharmacology EM facility since 2011 PI names highlighted in yellow Papers highlighted in grey originate from labs with PIs and trainees lacking EM … C Godbout, MA Hancock, JC Arezzo, O Ocal, C Rocha, N Olieric, A Hall pain 7 (10604), 2016 | | 2016 |
| Abstract A188: Diazonamide DZ 2384, a potential therapeutic for pancreatic cancer, binds to tubulin with a unique impact on microtubule dynamics and tubulin curvature M Wieczorek, J Tcherkezian, C Bernier, O Ocal, S Chabaan, Y Rolland, ... Molecular Cancer Therapeutics 14 (12_Supplement_2), A188-A188, 2015 | | 2015 |
| Reporter genes for a rapid in vivo screen of PDA therapeutics are required for energy homeostasis in pancreatic cancer-associated malnutrition O Ocal, Y Zolghadri, GH Swift, RA Brekken, TM Wilkie CANCER RESEARCH 75, 2015 | | 2015 |
| Abstract LB-130: Reporter genes for a rapid in vivo screen of PDA therapeutics are required for energy homeostasis in pancreatic cancer-associated malnutrition O Ocal, Y Zolghadri, GH Swift, RA Brekken, TM Wilkie Cancer Research 75 (15_Supplement), LB-130-LB-130, 2015 | | 2015 |
| Rapid in vivo Screen of Pancreatic Adenocarcinoma Therapeutics O Ocal, V Pashkov, G Swift, R Brekken, T Wilkie The FASEB Journal 29, 893.20, 2015 | | 2015 |
| Rgs8‐16 are Required for Energy Homeostasis in Pancreatic Cancer‐Associated Malnutrition Y Zolghadri, O Ocal, T Wilkie The FASEB Journal 29, 618.10, 2015 | | 2015 |
| A rapid in vivo screen for pancreatic ductal adenocarcinoma O Ocal, V Pashkov, RK Kollipara, Y Zolghadri, VH Cruz, MA Hale, ... | | 2015 |
| Abstract B19: Rapid in vivo screen of pancreatic ductal adenocarcinoma therapeutics O Ocal, B Heath, LB Rivera, V Pashkov, GH Swift, RA Brekken, TM Wilkie Molecular Cancer Therapeutics 12 (12_Supplement), B19-B19, 2014 | | 2014 |
| Rgs16 is a pancreatic reporter of chronic hyperglycemia in diabetes O Ocal | | 2012 |
| Abstract A98: Rgs16: HTS biomarker for pancreas development, diabetes, and PDAC. TM Wilkie, O Ocal, LB Rivera, RA Brekken Cancer Research 72 (14_Supplement), A98-A98, 2012 | | 2012 |
| Rgs16: HTS Biomarker for Pancreas Development, Cancer and Diabetes T Wilkie, O Ocal, R Brekken DIABETES 61, A722-A722, 2012 | | 2012 |
